Last reviewed · How we verify
Haloperidol and Ramelteon
Haloperidol and Ramelteon is a Small molecule drug developed by All India Institute of Medical Sciences, Bhubaneswar. It is currently FDA-approved.
At a glance
| Generic name | Haloperidol and Ramelteon |
|---|---|
| Sponsor | All India Institute of Medical Sciences, Bhubaneswar |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Haloperidol and Ramelteon CI brief — competitive landscape report
- Haloperidol and Ramelteon updates RSS · CI watch RSS
- All India Institute of Medical Sciences, Bhubaneswar portfolio CI
Frequently asked questions about Haloperidol and Ramelteon
What is Haloperidol and Ramelteon?
Haloperidol and Ramelteon is a Small molecule drug developed by All India Institute of Medical Sciences, Bhubaneswar.
Who makes Haloperidol and Ramelteon?
Haloperidol and Ramelteon is developed and marketed by All India Institute of Medical Sciences, Bhubaneswar (see full All India Institute of Medical Sciences, Bhubaneswar pipeline at /company/all-india-institute-of-medical-sciences-bhubaneswar).
What development phase is Haloperidol and Ramelteon in?
Haloperidol and Ramelteon is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing